Yahoo Finance report covering Carter Bankshares Inc. (CARE) market action, institutional positioning, and fundamental catalysts.
Why CARE Stock Traded Steady Today — RQD Quant Desk Flash
Carter Bankshares Inc. (CARE) carries a Roarable Rating of D+ (Sell) with 58/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is CARE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, Carter Bankshares Inc. (NASDAQ: CARE) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 58/100 at a spot price of $29.00 (0.00% 1D, market cap $642.8M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 7/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 12/20, and Executive Insider Alignment 14/20. Across 1097 tracked Financials issuers, CARE ranks #462 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does CARE compare to FBIZ and CCB in the Financials sector?
▼
Within the Financials sector (Major Banks), CARE carries a Roarable D+ (58/100 RQD), trailing P/E of 21.1x, gross margin of —, and ROIC of 7.5%. By comparison, FBIZ (First Business Financial Services Inc.) holds a B grade (73/100 RQD, P/E 12.3x, ROIC 13.5%, cap $647.7M) and CCB (Coastal Financial Corporation) posts a D grade (51/100 RQD, P/E 14.2x, ROIC 9.6%, cap $667.7M). Among the 5-stock peer group, FBIZ leads on earnings multiple (12.3x) while FBIZ leads on capital efficiency (13.5% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for CARE?
▼
Per CARE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001829576), Carter Bankshares Inc. generated $20.3M in revenue (+4.6% YoY), $31.4M in net income, and $31.8M in free cash flow against $4.85B in total assets and $0 in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
SEC Form 4 / 13F Thermometer: 70% Net Buy • Cannibal Buyback (-1.80% YoY Shares)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 6/9
Put hedging (50% put share) caps near-term gamma upside (-13 pts vs max)
⚔️ Adversarial Opposing Case: Why the CARE Bull Thesis Could Fail
Even with a 58/100 (D+) score, CARE faces multiple-compression risk if 21.1x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
Broader market pullbacks can still drag down strong stocks in the short run.
Dilution & Margin Drag: Cannibal Buyback (-1.80% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($30.54) or 200D SMA ($27.61) invalidates the momentum regime and cuts Target Base ($29.00) toward Bear Floor ($22.62).
Why CARE Stock Traded Steady Today — RQD Quant Desk Flash
Carter Bankshares Inc. (CARE) slipped 0.00% to $29.00, trading at 63% of its 52-week range ($16.78 – $36.06). Stretched risk/reward at 21x P/E (8% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 63% of its 52-week range ($16.78 – $36.06) with RSI-14 at 38.6 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±4.5% around $29.00 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D+ (Sell) backed by 52% gross margin and $31.8M annual free cash flow.
TradingView report covering Carter Bankshares Inc. (CARE) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Carter Bankshares Inc. (CARE) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Carter Bankshares Inc. (CARE) market action, institutional positioning, and fundamental catalysts.
Kalkine report covering Carter Bankshares Inc. (CARE) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Carter Bankshares Inc. (CARE) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Carter Bankshares Inc. (CARE) market action, institutional positioning, and fundamental catalysts.
Yahoo! Finance Canada report covering Carter Bankshares Inc. (CARE) market action, institutional positioning, and fundamental catalysts.
Carter Bankshares (NASDAQ:CARE) reported quarterly earnings of $0.35 per share which missed the analyst consensus estimate of $0.53 by 33.96 percent. This is a 34.62 percent increase over earnings of $0.26 per share
Esquire Financial (ESQ) delivered earnings and revenue surprises of +12.17% and +2.50%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CARE)
- ✓Walkthrough of CARE's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
CARE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +4.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CARE today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CARE. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CARE)
1. Head-to-Head Financials Peer Comparison (CARE vs. FBIZ, CCB, WCCB, ACNB)
Industry: Major Banks (248 Tracked Issuers)Across 1097 tracked Financials securities in the Roarable RQD universe, Carter Bankshares Inc. (CARE) ranks #462 by composite RQD confidence (58/100, grade D+) and #649 by equity capitalization ($642.8M). Within this direct 5-issuer industry benchmark cohort, FBIZ leads on earnings valuation at 12.3x trailing P/E, while FBIZ leads on capital efficiency and profitability with 13.5% ROIC and — gross margin. FBIZ currently holds the highest overall quantitative score in the immediate peer group at 73/100 (B) compared with CARE at 58/100 (D+).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| CARE
ACTIVE
Carter Bankshares Inc. | D+ | 58/100 | 21.1x | — | 7.5% | 0.00% | $642.8M | Benchmark Subject |
| FBIZ First Business Financial Services Inc. | B | 73/100 | 12.3x | — | 13.5% | +3.14% | $647.7M | /fbiz-vs-care → |
| CCB Coastal Financial Corporation | D | 51/100 | 14.2x | — | 9.6% | +0.90% | $667.7M | /ccb-vs-care → |
| WCCB West Coast Community Bancorp | C- | 60/100 | — | — | — | +0.71% | $667.9M | /wccb-vs-care → |
| ACNB ACNB Corporation | B- | 71/100 | 18.0x | — | 8.8% | +2.63% | $682.6M | /acnb-vs-care → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001829576 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), Carter Bankshares Inc. (CARE) reported GAAP revenue of $20.3M (+4.6% vs. FY2024 revenue of $19.4M , and +17.7% cumulative change since FY2023) , GAAP net income of $31.4M, operating cash flow of $39.9M, and free cash flow of $31.8M (+10.4% YoY). On the balance sheet, CARE closed FY2025 with $4.85B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 6/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $20.3M | $31.4M | $39.9M | $31.8M | $4.85B | — |
| FY2024 (FY) | 2024-12-31 | $19.4M | $24.5M | $36.9M | $28.8M | $4.66B | — |
| FY2023 (FY) | 2023-12-31 | $17.3M | $23.4M | $46.7M | $46.7M | — | — |
3. CARE Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs CARE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, Carter Bankshares Inc. (NASDAQ: CARE) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 58/100 at a spot price of $29.00 (0.00% 1D, market cap $642.8M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 7/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 12/20, and Executive Insider Alignment 14/20. Across 1097 tracked Financials issuers, CARE ranks #462 in composite RQD confidence.
How does CARE compare to FBIZ and CCB in the Financials sector?
Within the Financials sector (Major Banks), CARE carries a Roarable D+ (58/100 RQD), trailing P/E of 21.1x, gross margin of —, and ROIC of 7.5%. By comparison, FBIZ (First Business Financial Services Inc.) holds a B grade (73/100 RQD, P/E 12.3x, ROIC 13.5%, cap $647.7M) and CCB (Coastal Financial Corporation) posts a D grade (51/100 RQD, P/E 14.2x, ROIC 9.6%, cap $667.7M). Among the 5-stock peer group, FBIZ leads on earnings multiple (12.3x) while FBIZ leads on capital efficiency (13.5% ROIC).
What are the biggest fundamental strengths and SEC risk factors for CARE?
Per CARE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001829576), Carter Bankshares Inc. generated $20.3M in revenue (+4.6% YoY), $31.4M in net income, and $31.8M in free cash flow against $4.85B in total assets and $0 in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.
Where is CARE trading relative to its 50-day, 200-day, and 52-week technical levels?
CARE last traded at $29.00 (0.00% on volume of 280,783 shares), positioning the stock -5.04% below its 50-day simple moving average ($30.54) and +5.03% above its 200-day simple moving average ($27.61). Across its 52-week range of $16.78 to $36.06, CARE sits at the 63.4% percentile with a 14-day RSI of 38.6 (NEUTRAL RANGE) and an implied next-earnings move of ±4.5% ($27.70 to $30.30).
CARE — Carter Bankshares Inc.: What the Facts Mean to a Prospective Investor
1. Roarable Rating Brief: What This Means to a Prospective Investor
Carter Bankshares Inc. (CARE) earns a live Roarable RQD composite score of 58/100, corresponding to a D+ letter grade (Roarable Sell) at a spot price of $29.00 (0.00% 1D, market capitalization $642.8M).
- Fundamental Cash Engine (12/20): Anchored by return on invested capital (ROIC) of 7.5%, gross margin of —, operating margin of —, and free cash flow yield of 4.80%.
- Whale 13F & Options Flow (7/20) + Insider Conviction (14/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (12/20) + Forensic Balance Sheet (13/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 6/9, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
Carter Bankshares Inc. Is a NASDAQ-listed issuer classified in the Financials sector and the Major Banks industry, . The profile identifies the company's market capitalization as $0.7B. — Specific product lines, customer segments, and revenue model details are not described in the source data.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Carter Bankshares Inc. (CARE) reported $20.3M in annual revenue (up from $19.4M in FY2024, +4.6% YoY) and $31.4M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($17.3M revenue, $23.4M net income) through FY2025, CARE scaled operating cash flow to $39.9M and free cash flow to $31.8M, backed by $4.85B in total assets against $0 in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (D+ • RQD 58/100): Company leadership has skin in the game with net positive insider conviction. Free cash flow yield of 4.80% and institutional whale pillar of 7/20. With Fundamental Cash Engine at 12/20 and Institutional Whale Flow at 7/20, sustained execution supports upside toward the upper end of the $16.78 – $36.06 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Broader market pullbacks can still drag down strong stocks in the short run. Investors must weigh 21.1x trailing P/E against — operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
— The Butterfly Supply-Chain Graph records no upstream or downstream dependencies, no sector correlations, and no proprietary signals for CARE.
- Key Question #1: Can CARE sustain or expand its — operating margin and 7.5% ROIC against Major Banks peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $20.3M and free cash flow of $31.8M, how will capital allocation balance growth reinvestment against $0 in total debt?
- Key Question #3: How sensitive is CARE's 19.6x forward P/E multiple to Financials capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
CARE Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for Carter Bankshares Inc. (CARE) • Click "Debate This Headline" to argue it in the Roar Pit below
Yahoo Finance report covering Carter Bankshares Inc. (CARE) market action, institutional positioning, and fundamental catalysts.
TradingView report covering Carter Bankshares Inc. (CARE) market action, institutional positioning, and fundamental catalysts.
Yahoo Finance report covering Carter Bankshares Inc. (CARE) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering Carter Bankshares Inc. (CARE) market action, institutional positioning, and fundamental catalysts.
Kalkine report covering Carter Bankshares Inc. (CARE) market action, institutional positioning, and fundamental catalysts.
MarketBeat report covering Carter Bankshares Inc. (CARE) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering Carter Bankshares Inc. (CARE) market action, institutional positioning, and fundamental catalysts.
Yahoo! Finance Canada report covering Carter Bankshares Inc. (CARE) market action, institutional positioning, and fundamental catalysts.
CARE Bull vs. Bear Conversation Board — What's Your Call at $29.00?
Insider conviction scores 14 of 20 and the 13 of 20 forensic balance sheet reflects Altman Z 2.5 and Piotroski F 6/9.
Don't sleep on CARE's setup in Financials. Insider conviction scores 14 of 20 and the 13 of 20 forensic balance sheet reflects Altman Z 2.5 and Piotroski F 6/9.. Beta of 1.0 means it moves fast when momentum turns, and the 5-pillar RQD gauge (58/100) backs up the fundamental quality.
@SiliconVal_Bull Agree on the RQD 58/100 quality, though with 1.0 beta I'm scaling in with half-size at $29.00 and keeping dry powder in case we test $26.97.
Whale 13F flow scores only 10 of 20 and the Q3 earnings-miss headline is flagged RED as RISK WATCH.
I respect the product at Carter Bankshares Inc., but the stock at $29.00 is a different story. Whale 13F flow scores only 10 of 20 and the Q3 earnings-miss headline is flagged RED as RISK WATCH.. FCF yield is 4.8% and RQD sits at 58/100 (D+) — why pay up here when you can wait for next quarter's numbers?